These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27679977)

  • 1. Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Roychowdhury S; Goswami S; Ippolito JE; Priceman SJ; Pritchard CC; Sfanos KS; Subudhi SK; Simons JW; Pienta KJ; Soule HR
    Prostate; 2017 Feb; 77(2):123-144. PubMed ID: 27679977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Cheng HH; Abida W; Ellis L; Harshman LC; Spratt DE; Simons JW; Pienta KJ; Soule HR
    Prostate; 2017 Nov; 77(15):1478-1488. PubMed ID: 28925066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Lang JM; Den RB; Garraway IP; Lotan TL; Ross AE; Stoyanova T; Cho SY; Simons JW; Pienta KJ; Soule HR
    Prostate; 2016 Feb; 76(2):125-39. PubMed ID: 26477609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Den RB; Carlo MI; de Leeuw R; Hope TA; Karzai F; McKay RR; Salami SS; Simons JW; Pienta KJ; Soule HR
    Prostate; 2019 Feb; 79(3):244-258. PubMed ID: 30381857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting.
    Miyahira AK; Zarif JC; Coombs CC; Flavell RR; Russo JW; Zaidi S; Zhao D; Zhao SG; Pienta KJ; Soule HR
    Prostate; 2022 Feb; 82(2):169-181. PubMed ID: 34734426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.
    Miyahira AK; Hawley JE; Adelaiye-Ogala R; Calais J; Nappi L; Parikh R; Seibert TM; Wasmuth EV; Wei XX; Pienta KJ; Soule HR
    Prostate; 2023 Feb; 83(3):207-226. PubMed ID: 36443902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Sharp A; Ellis L; Jones J; Kaochar S; Larman HB; Quigley DA; Ye H; Simons JW; Pienta KJ; Soule HR
    Prostate; 2020 Feb; 80(2):113-132. PubMed ID: 31825540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.
    Miyahira AK; Kissick HT; Bishop JL; Takeda DY; Barbieri CE; Simons JW; Pienta KJ; Soule HR
    Prostate; 2015 Mar; 75(4):337-47. PubMed ID: 25358693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey-Holden Prostate Cancer Academy Meeting.
    Miyahira AK; Kamran SC; Jamaspishvili T; Marshall CH; Maxwell KN; Parolia A; Zorko NA; Pienta KJ; Soule HR
    Prostate; 2024 Aug; 84(11):993-1015. PubMed ID: 38682886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.
    Miyahira AK; Morris M; Soule HR;
    Prostate; 2017 Feb; 77(3):245-254. PubMed ID: 27800631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 22nd annual prostate cancer foundation scientific retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2016 Sep; 76(12):1037-52. PubMed ID: 27272144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 24th Annual Prostate Cancer Foundation scientific retreat report.
    Miyahira AK; Soule HR
    Prostate; 2018 Sep; 78(12):867-878. PubMed ID: 29761524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 23rd Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Soule HR
    Prostate; 2017 Jul; 77(10):1093-1106. PubMed ID: 28503903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 20th Annual Prostate Cancer Foundation Scientific Retreat report.
    Miyahira AK; Simons JW; Soule HR
    Prostate; 2014 Jun; 74(8):811-9. PubMed ID: 24719035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 27th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2021 Nov; 81(15):1107-1124. PubMed ID: 34469608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer immunotherapy: where are we and where are we going?
    De Velasco MA; Uemura H
    Curr Opin Urol; 2018 Jan; 28(1):15-24. PubMed ID: 29095729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: Better VISTAs ahead? Potential and pitfalls of immunotherapy.
    Madan RA; Gulley JL
    Nat Rev Urol; 2017 Aug; 14(8):455-456. PubMed ID: 28534538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting.
    Pienta KJ; Walia G; Simons JW; Soule HR
    Prostate; 2014 Feb; 74(3):314-20. PubMed ID: 24249419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targets for metastatic prostate cancer.
    Timme TL; Satoh T; Tahir SA; Wang H; Teh BS; Butler EB; Miles BJ; Amato RJ; Kadmon D; Thompson TC
    Curr Drug Targets; 2003 Apr; 4(3):251-61. PubMed ID: 12643475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.
    Miyahira AK; Soule HR
    Prostate; 2021 Jan; 81(1):3-19. PubMed ID: 33085787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.